Multiparametric MRI-based radiomics combined with pathomics features for prediction of the efficacy of neoadjuvant chemotherapy in breast cancer
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82060313)
- National Natural Science Foundation of China (82160340)
- Kunming Medical University
- Yunnan Provincial Science and Technology Department (202301AY070001-243)
This publication has 39 references indexed in Scilit:
- Spatial Bayesian modeling of GLCM with application to malignant lesion characterizationJournal of Applied Statistics, 2018
- Radiomics: the bridge between medical imaging and personalized medicineNature Reviews Clinical Oncology, 2017
- Automatic cellularity assessment from post‐treated breast surgical specimensCytometry Part A, 2017
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent seriesThe Journal of Pathology: Clinical Research, 2015
- Pathological Complete Response in Neoadjuvant Treatment of Breast CancerAnnals of Surgical Oncology, 2015
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisThe Lancet, 2014
- Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to TherapyPathology and Oncology Research, 2014
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- Role of MRI in screening, diagnosis and management of breast cancerExpert Review of Anticancer Therapy, 2008